Deferred Tax Assets, Operating Loss Carryforwards of Propanc Biopharma, Inc. from 30 Jun 2013 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Propanc Biopharma, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Jun 2013 to 30 Jun 2025.
  • Propanc Biopharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Jun 2025 was $25,483,996, a 181% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $25,483,996 +$16,408,967 +181% 30 Jun 2025 10-K 29 Sep 2025 2025 FY
Q2 2024 $9,075,029 +$164,155 +1.8% 30 Jun 2024 10-K 29 Sep 2025 2025 FY
Q2 2023 $8,910,874 +$151,517 +1.7% 30 Jun 2023 10-K 30 Sep 2024 2024 FY
Q2 2022 $8,759,357 +$212,437 +2.5% 30 Jun 2022 10-K 28 Sep 2023 2023 FY
Q2 2021 $8,546,920 +$1,108,009 +15% 30 Jun 2021 10-K 28 Sep 2022 2022 FY
Q2 2020 $7,438,911 +$865,696 +13% 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q2 2019 $6,573,215 +$904,472 +16% 30 Jun 2019 10-K 01 Oct 2020 2020 FY
Q2 2018 $5,668,743 30 Jun 2018 10-K 15 Oct 2019 2019 FY
Q2 2015 $77,470 +$29,203 +61% 30 Jun 2015 10-K 30 Sep 2015 2015 FY
Q2 2014 $48,267 -$12,194 -20% 30 Jun 2014 10-K 30 Sep 2015 2015 FY
Q2 2013 $60,461 30 Jun 2013 10-K 14 Oct 2014 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.